PROCEPT (PRCT) CFO Kevin Waters Sells 357 Shares

What Happened

• Kevin Waters, EVP and CFO of PROCEPT BioRobotics (PRCT), sold 357 shares on June 8, 2026 at $28.48 per share, producing reported proceeds of $10,167. The filing shows this was a sale (disposition) tied to tax withholding.

Key Details

• Transaction date and price: June 8, 2026 — 357 shares at $28.48 each.
• Proceeds reported: $10,167 (rounded).
• Shares owned after transaction: Not reported in the provided filing.
• Footnote: The shares were sold pursuant to the issuer’s sell-to-cover process to satisfy tax withholding obligations related to Restricted Stock Units that vested on June 5, 2026 (footnote F1).
• Filing date/timeliness: Form 4 filed June 10, 2026 (within the typical two-business-day reporting window); not flagged as late.

Context

• This was a routine sell-to-cover to satisfy tax withholding from RSU vesting, which is common and does not by itself indicate a change in the insider’s view of the company. Sales for tax withholding generally carry less informational weight than discretionary open-market sales.